This is a solicitation of funds for the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) Postdoctoral Fellows in Regulatory Science Program.
The objective of the program is to train the next generation of regulatory scientists. Regulatory science is the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of products regulated by the Food and Drug Administration (FDA). Regulatory science projects at M-CERSI and the University of Maryland range from drug and biologics discovery to pharmaceutical quality, clinical research, and post-marketing surveillance.
Each fellow is mentored by a team of three scientists -- one from industry, one from the University System of Maryland, and one from the FDA. Each fellowship is two years in duration, with the first year spent at the University of Maryland and second year spent at either the FDA or in an industrial setting. Additional training of fellows involves M-CERSI-related activities, such as courses, workshops, and lectures at FDA.
If you or someone you know might be interested in supporting this program, please contact:
James E. Polli, PhD
Professor and Ralph F. Shangraw/Noxell Endowed Chair in Industrial Pharmacy and Pharmaceutics
University of Maryland School of Pharmacy
20 Penn Street, Room 623
Baltimore, MD 21201
Phone: (410) 706-8292
|A collaborative partnership between the University of Maryland, College Park and the University of Maryland, Baltimore, with support from the Food and Drug Administration (FDA), the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) focuses on modernizing and improving the ways drugs and medical devices are reviewed and evaluated.|